Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1
about
Carcinoma of unknown primary originAnalysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancerCauses of death in patients with extranodal cancer of unknown primary: searching for the primary site.Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trialComparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.Toward angiogenesis of implanted bio-artificial liver using scaffolds with type I collagen and adipose tissue-derived stem cellsForty years experience of treating cancer of unknown primary.Antitumor activity and inhibitory effects on cancer stem cell-like properties of Adeno-associated virus (AAV) -mediated Bmi-1 interference driven by Bmi-1 promoter for gastric cancer.High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis.Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks.Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary.Correlation between TSP-1, TGF-β and PPAR-γ expression levels and glioma microvascular density.Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.
P2860
Q28237221-F0ABF672-1105-4365-BC1E-4D2488A6B123Q31126032-CB11F266-2CB3-4343-A82F-B7CA0A32CE0FQ33753455-463687DB-C386-4E6A-A8E3-7FCC5F936252Q33830156-BBE0C77B-9160-4BB5-9E13-3C9D6F48B367Q34344696-141445F0-C22E-43B7-A8D2-2B6382B78BABQ34565458-E9D85F9C-668D-4BF2-9D95-2D3D24095DB7Q35806543-9FAFAA5C-B8F7-459E-837A-024E4C90E441Q35826262-E8B82238-A284-4B84-9329-5F679765CA21Q36846898-43B3B900-9ADE-4510-9A63-73B56C1C52B2Q37225659-7EA54C42-FCB8-4BD9-9FFE-ECA96C03AAA2Q37321347-2E468F8D-E377-417F-857A-0771C1A40A48Q38088368-7DE5E6ED-8E88-473A-BAED-D2ED459CF98CQ41487406-0A523CDB-1581-4BE5-A862-F196E34E7407Q42801338-1D74C8C6-820B-4C03-8451-38A911B59A35Q54515534-DEF022F5-BBD9-4FEA-AC3D-179789CCA0DC
P2860
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@ast
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@en
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@nl
type
label
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@ast
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@en
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@nl
prefLabel
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@ast
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@en
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@nl
P2093
P2860
P356
P1433
P1476
Angiogenesis in cancer of unkn ...... study of CD34, VEGF and TSP-1
@en
P2093
Elena Tsanou
Evangelia Kitsou
Evangelos Briasoulis
George Fountzilas
Nicholas Pavlidis
Theodore Fotsis
Vasiliki Malamou-Mitsi
P2860
P2888
P356
10.1186/1471-2407-5-25
P407
P577
2005-03-03T00:00:00Z
P5875
P6179
1042585405